Reducing inflammation without lowering cholesterol cuts risk of cardiovascular events

The companies are “unscrupulous actors” marketing stem-cell treatments that have not been proved effective and may be dangerous, the FDA says. It took action against clinics in Florida and California.

Read More »

Comments

comments

LEAVE A COMMENT